The discovery that autosomal dominant forms of AD are attributable to mutated genes coding for APP or one of the presenilins, proteins that contain the catalytic activity of gamma-secretase, releasing Aß from APP, prompted continuous efforts to establish ‘transgenic mice models of AD’ for therapeutic research. Here, APP is linked to Alzheimer disease.